Join
Live feed
·
PRReleasevia Quantisnow
Akers Biosciences Inc. logo

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

ByQuantisnow·Wall Street's wire, on your screen.
AKER· Akers Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKER (Akers Biosciences Inc.) and more on Quantisnow.